ArticleCureus2025
Neostigmine-Atropine Combination Triggered Stress Cardiomyopathy in a Healthy Patient: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stress-induced cardiomyopathy or Takotsubo syndrome represents a short-term heart condition that develops after experiencing sudden physical or emotional distress. The condition primarily affects postmenopausal women under stress, but drug-induced cases remain both uncommon and poorly identified. A 40-year-old female patient without heart conditions developed stress-induced cardiomyopathy after receiving standard-dose neostigmine-atropine during her elective laparoscopic cholecystectomy. The patient developed ventricular fibrillation, which needed immediate resuscitation just 50 seconds after drug administration. The patient developed Takotsubo cardiomyopathy symptoms with apical ballooning and severe mid-apical hypokinesis according to imaging results, even though coronary angiography showed normal results. The case demonstrates that neostigmine-atropine can cause serious cardiac issues in people with low-risk profiles and suggests using sugammadex as a safer alternative when available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.